189 related articles for article (PubMed ID: 15788155)
21. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
Niu XL; Xia Y; Hoshiai K; Tanaka K; Sawamura S; Nakazawa H
Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
[TBL] [Abstract][Full Text] [Related]
22. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.
Shirey KA; Cole LE; Keegan AD; Vogel SN
J Immunol; 2008 Sep; 181(6):4159-67. PubMed ID: 18768873
[TBL] [Abstract][Full Text] [Related]
23. Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.
Cowley SC; Sedgwick JD; Elkins KL
J Immunol; 2007 Dec; 179(11):7709-19. PubMed ID: 18025217
[TBL] [Abstract][Full Text] [Related]
24. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells.
Telepnev M; Golovliov I; Sjöstedt A
Microb Pathog; 2005; 38(5-6):239-47. PubMed ID: 15925273
[TBL] [Abstract][Full Text] [Related]
25. Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape.
McCaffrey RL; Allen LA
J Leukoc Biol; 2006 Dec; 80(6):1224-30. PubMed ID: 16908516
[TBL] [Abstract][Full Text] [Related]
26. Delayed presence of alternatively activated macrophages during a Francisella tularensis infection.
D'Elia RV; Laws TR; Núñez A; Taylor C; Clark GC
Microb Pathog; 2015 Jan; 78():37-42. PubMed ID: 25284816
[TBL] [Abstract][Full Text] [Related]
27. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
Elkins KL; Colombini SM; Meierovics AI; Chu MC; Chou AY; Cowley SC
Microbes Infect; 2010 Jan; 12(1):28-36. PubMed ID: 19781659
[TBL] [Abstract][Full Text] [Related]
28. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors.
Pierini LM
Cell Microbiol; 2006 Aug; 8(8):1361-70. PubMed ID: 16882038
[TBL] [Abstract][Full Text] [Related]
29. Rapid onset of ICAM-1 expression is a marker of effective macrophages activation during infection of Francisella tularensis LVS in vitro.
Novosad J; Holicka M; Novosadova M; Krejsek J; Krcmova I
Folia Microbiol (Praha); 2011 Mar; 56(2):149-54. PubMed ID: 21476047
[TBL] [Abstract][Full Text] [Related]
30. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication.
Collazo CM; Sher A; Meierovics AI; Elkins KL
Microbes Infect; 2006 Mar; 8(3):779-90. PubMed ID: 16513388
[TBL] [Abstract][Full Text] [Related]
31. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin.
Balish E; Warner TF; Nicholas PJ; Paulling EE; Westwater C; Schofield DA
Infect Immun; 2005 Mar; 73(3):1313-20. PubMed ID: 15731028
[TBL] [Abstract][Full Text] [Related]
33. Response of alveolar macrophages from inducible nitric oxide synthase knockout or wild-type mice to an in vitro lipopolysaccharide or silica exposure.
Zeidler PC; Roberts JR; Castranova V; Chen F; Butterworth L; Andrew ME; Robinson VA; Porter DW
J Toxicol Environ Health A; 2003 Jun; 66(11):995-1013. PubMed ID: 12775513
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
Green M; Choules G; Rogers D; Titball RW
Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W
Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525
[TBL] [Abstract][Full Text] [Related]
36. Lipoarabinomannan from Mycobacterium tuberculosis modulates the generation of reactive nitrogen intermediates by gamma interferon-activated macrophages.
Anthony LS; Chatterjee D; Brennan PJ; Nano FE
FEMS Immunol Med Microbiol; 1994 May; 8(4):299-305. PubMed ID: 8061654
[TBL] [Abstract][Full Text] [Related]
37. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani.
Murray HW; Nathan CF
J Exp Med; 1999 Feb; 189(4):741-6. PubMed ID: 9989990
[TBL] [Abstract][Full Text] [Related]
38. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
39. Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro.
Loegering DJ; Drake JR; Banas JA; McNealy TL; Mc Arthur DG; Webster LM; Lennartz MR
Microb Pathog; 2006 Dec; 41(6):218-25. PubMed ID: 16996713
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes.
Hong KJ; Wickstrum JR; Yeh HW; Parmely MJ
Infect Immun; 2007 Nov; 75(11):5338-45. PubMed ID: 17785474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
